Related Experiment Video
Updated: Jun 11, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
A Mobile Application for Anticoagulation Management in Patients After Heart Valve Replacement: A Usability Study
Xia Yuan1,2, Shenmin Wan1,2, Wenshuo Wang2,3
1Department of Nursing, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
An AI-powered mobile app for anticoagulation management shows promise for heart valve replacement patients. Usability testing confirmed high acceptance among patients, doctors, and nurses, indicating feasibility for improved self-management.
Area of Science:
- Biomedical Engineering
- Digital Health
- Artificial Intelligence in Medicine
Background:
- Individualized anticoagulation therapy is crucial but challenging for patients post-heart valve replacement.
- Mobile applications integrated with Artificial Intelligence (AI) offer a potential solution for personalized patient care.
- This study explores the development and feasibility of an AI-assisted mobile app for anticoagulation management.
Purpose of the Study:
- To develop an AI technology-assisted mobile application for anticoagulation management.
- To assess patient acceptance of such a mobile application.
- To determine the overall feasibility of the AI-assisted anticoagulation management app.
Main Methods:
- An AI-assisted mobile application was developed for anticoagulation management.
- Usability was evaluated using the System Usability Scale (SUS) after 2 weeks of use.
- Semi-structured interviews were conducted with patients, doctors, and nurses to gather qualitative feedback.
Main Results:
- The study included 80 participants: 38 patients, 18 doctors, and 24 nurses.
- High usability scores were reported: Patients (82.37±5.45), Doctors (84.17±5.82), and Nurses (81.88±6.44).
- Interviews revealed patient satisfaction with ease of use, desire for precise dosage recommendations, and concerns about data security; healthcare professionals noted potential for improved self-management, especially with family support for elderly patients.
Conclusions:
- The AI-assisted mobile application is feasible for anticoagulation management in post-heart valve replacement patients.
- Future development should focus on enhancing dose recommendation accuracy, securing family support, and ensuring data privacy.
- The app demonstrates potential to improve patient self-management and convenience in transitional care settings.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Peripheral Artery Disease V: Postoperative Nursing Management

